By Sheeba M. | April 20, 2026
The Hidden Yield Plays in Cannabis Debt — Why Operators Are Turning to Structured Financing
The cannabis industry’s equity markets have been brutal for three years. MSO stocks trade at fractions of their 2021 highs, and traditional bank financing remains effectively cut off due to federal illegality. But in the shadows of that struggle, a quieter story is unfolding: structured debt is generating outsized yields for investors who know where to look.
What Is Cannabis Structured Debt?
Structured debt in cannabis typically comes in three forms: convertible notes, senior secured term loans, and revenue-sharing arrangements. Unlike public equity — which gets crushed when sentiment sours — these instruments sit higher in the capital stack and carry contractual cash flow rights.
Consider a typical senior secured loan to a mid-tier MSO: interest rates of 12-18% annually, with principal secured against specific assets (cultivation facilities, retail leases, brand IP). Some loans include warrants, giving lenders upside if the company recovers. Others have revenue participation — a percentage of top-line revenue until the loan is repaid.
“We’re seeing operators who burned through their equity capital come back to structured lenders at terms that look very attractive from a yield perspective,” said a managing director at a cannabis-focused credit fund, speaking on background. “The equity guys got wiped out in ’22 and ’23. The debt guys are doing fine.”
Key Players and Instruments to Watch
Several publicly traded entities have positioned themselves in cannabis debt. ACRHF (Acreage Holdings) has used convertible structures to extend runway. CURLF (Curaleaf) disclosed in its most recent 10-Q that it had outstanding convertible notes totaling $175 million at 9.5% — notably cheaper than the 15-20% rates smaller operators pay in the private market.
On the pure-play side, cannabis-focused credit funds like Bespoke Capital and Silver Spike Capital have been deploying capital into structured deals at yields ranging from 15% to 22%. Some deals include equity kickers that, if the underlying company recovers, can multiply returns substantially.
Risks and What to Watch
These instruments aren’t without risk. Liquidity is thin — you can’t just sell a private credit arrangement on the open market. And if an operator goes bankrupt, recovery depends heavily on asset quality and where your instrument sits in the waterfall.
For retail investors, direct access to cannabis debt is limited. But ETFMs like MSOS (AdvisorShares Pure US Cannabis ETF) hold equity in companies that themselves have debt structures — so you’re getting some indirect exposure. And some cannabis REITs — GFCRF (Green Fox Realty) — function partly as debt vehicles against cultivation real estate.
The bigger signal: as long as federal reform stays stalled, debt instruments will continue to fill the financing gap. Investors who understand this layer of cannabis capital structure have an edge.
Sources
- SEC EDGAR — Curaleaf 10-Q (Q4 2025 convertible note disclosures)
- Bespoke Capital — Cannabis credit market overview and deal flow
- Bloomberg Cannabis Intelligence — MSO debt structure analysis and yield data
Track cannabis stocks with the Weedstock Real-Time Tracker